CN105189531B - 用于皮肤复新的肽及其使用方法 - Google Patents

用于皮肤复新的肽及其使用方法 Download PDF

Info

Publication number
CN105189531B
CN105189531B CN201480012627.7A CN201480012627A CN105189531B CN 105189531 B CN105189531 B CN 105189531B CN 201480012627 A CN201480012627 A CN 201480012627A CN 105189531 B CN105189531 B CN 105189531B
Authority
CN
China
Prior art keywords
skin
composition
collagen
acid
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480012627.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN105189531A (zh
Inventor
F·德莱赫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteis SA
Original Assignee
Anteis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis SA filed Critical Anteis SA
Publication of CN105189531A publication Critical patent/CN105189531A/zh
Application granted granted Critical
Publication of CN105189531B publication Critical patent/CN105189531B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480012627.7A 2013-03-13 2014-02-26 用于皮肤复新的肽及其使用方法 Active CN105189531B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361779601P 2013-03-13 2013-03-13
US61/779,601 2013-03-13
PCT/IB2014/001119 WO2014140890A2 (en) 2013-03-13 2014-02-26 Peptides for skin rejuvenation and methods of using the same

Publications (2)

Publication Number Publication Date
CN105189531A CN105189531A (zh) 2015-12-23
CN105189531B true CN105189531B (zh) 2020-02-21

Family

ID=51263427

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480012627.7A Active CN105189531B (zh) 2013-03-13 2014-02-26 用于皮肤复新的肽及其使用方法

Country Status (13)

Country Link
US (3) US9375398B2 (enExample)
EP (1) EP2970382B1 (enExample)
JP (1) JP6326601B2 (enExample)
KR (1) KR102276326B1 (enExample)
CN (1) CN105189531B (enExample)
AR (1) AR095276A1 (enExample)
AU (1) AU2014229557B2 (enExample)
CA (1) CA2902938C (enExample)
MX (1) MX360649B (enExample)
RU (1) RU2666533C2 (enExample)
SG (1) SG11201506069RA (enExample)
TW (1) TWI652066B (enExample)
WO (1) WO2014140890A2 (enExample)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902938C (en) 2013-03-13 2021-06-01 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
WO2015069843A2 (en) 2013-11-08 2015-05-14 Hollister Incorporated Oleophilic lubricated catheters
MX367806B (es) 2013-12-20 2019-09-06 Colgate Palmolive Co Partículas de sílice de núcleo-cubierta y uso para reducción del mal olor.
US11400032B2 (en) 2013-12-20 2022-08-02 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
BR112017000937B1 (pt) * 2014-07-31 2022-01-25 Kimberly-Clark Worldwide, Inc. Composição antiaderente e lenço
RU2709778C2 (ru) * 2014-12-23 2019-12-20 Эйвон Продактс, Инк. Пептиды и их применение в уходе за кожей
JP2016150919A (ja) * 2015-02-18 2016-08-22 ピアス株式会社 塗布用化粧品組成物
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
ITUB20152695A1 (it) * 2015-07-31 2017-01-31 Metis Healthcare S R L Composizione per l'aumento delle secrezioni umorali
JP6864001B2 (ja) 2015-11-03 2021-04-21 ゾエティス・サービシーズ・エルエルシー ゾル−ゲルポリマー組成物及びそれらの使用
MX382934B (es) 2015-12-24 2025-03-13 Unilever Ip Holdings B V Inhibidores de tirosinasa.
KR101843065B1 (ko) * 2016-01-06 2018-03-28 바이오스펙트럼 주식회사 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물
CN106975523A (zh) * 2016-01-19 2017-07-25 广州绿恒环保科技有限公司 一种新型的具有渗透分解功能光触媒液体
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
AU2016389266B2 (en) 2016-01-28 2021-07-01 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
US20170216584A1 (en) * 2016-01-29 2017-08-03 Insung Information Co., Ltd. Sheet mask for iontophoresis and mask assembly using the same
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10988731B2 (en) * 2016-04-29 2021-04-27 Hope Biosciences, Llc Formulation for storage, transportation, and delivery of protein rich conditioned medium
JP6489487B2 (ja) * 2017-01-20 2019-03-27 富比積生物科技股▲分▼有限公司 テトラペプチド−３ ｇｅｋｇまたはペンタペプチド−３ ｇｅｋｇｆにより変形性関節症を治療するための新規用途
EP3582745B1 (en) 2017-02-17 2021-06-30 ImerTech SAS Use of a particulate mineral to reduce pollution
US20180296456A1 (en) * 2017-03-30 2018-10-18 Escape Therapeutics, Inc. Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte Progenitors
KR101956572B1 (ko) * 2017-04-05 2019-06-24 에이앤펩주식회사 기능성 펩타이드와 콜라겐 발효물을 포함하는 주름 개선용 조성물
EP3606500B1 (en) * 2017-04-07 2023-10-04 Weidmann Holding AG Personal care composition
CN107308101B (zh) * 2017-06-13 2020-06-19 湖南御家化妆品制造有限公司 皮肤紧致组合物及其应用
US20210137809A1 (en) * 2017-06-14 2021-05-13 Biosolution Co., Ltd Cosmetic composition for wrinkle reduction or anti-inflammation, containing substance p
US10258556B2 (en) * 2017-06-19 2019-04-16 Yu-Chun Liu Anti-aging peptide, its composition and method of using the same
AU2018309058B2 (en) * 2017-08-03 2023-02-16 ALASTIN Skincare, Inc. Compositions and methods for ameliorating skin laxity and body contour
IT201700102009A1 (it) * 2017-09-12 2019-03-12 Promoitalia Group Spa Composizione rigenerante e ad azione levigante per il trattamento degli inestetismi della pelle e relativo procedimento di preparazione
WO2019056007A1 (en) * 2017-09-18 2019-03-21 Incube Labs Llc IONTOPHORETIC SYSTEMS, KITS AND METHODS FOR TRANSDERMAL DELIVERY OF COSMETIC AGENTS
CN107857799B (zh) * 2017-11-20 2021-06-04 陕西慧康生物科技有限责任公司 一种四肽-21的液相合成方法
US11298306B2 (en) 2017-12-12 2022-04-12 Colgate-Palmolive Company Personal care composition
CN108218956A (zh) * 2018-02-23 2018-06-29 广州同隽医药科技有限公司 一种棕榈酰三肽-1的液相合成方法
FR3080532A1 (fr) * 2018-04-26 2019-11-01 Codexial Dermatologie Preparation magistrale dermatologique
WO2019213473A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
CN108744024A (zh) * 2018-05-24 2018-11-06 海南芬森医疗器械有限公司 一种复配防疤痕液剂生物敷料及其制备方法
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
CN108888799A (zh) * 2018-06-25 2018-11-27 东莞市联洲知识产权运营管理有限公司 一种具有驱虫性能的增强型复合纤维素医用敷料及其制备方法
KR101924894B1 (ko) * 2018-07-25 2018-12-04 베네브바이오랩 주식회사 소음순 피부 치료용 피부연고
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
US20210187208A1 (en) * 2018-08-23 2021-06-24 The General Hospital Corporation Multifunctional skin patch
KR101965607B1 (ko) * 2018-08-27 2019-04-04 (주)씨앤케이코스메디칼 불연속상 하이드로겔 및 옥수수 전분을 결합제로 포함하는 외력붕해성 고형 클렌저 및 이의 제조 방법
RU2681310C1 (ru) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala
RU2681216C1 (ru) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala
US10881882B1 (en) * 2018-12-21 2021-01-05 Btl Medical Technologies S.R.O. Methods and devices for tissue treatment
GB201900728D0 (en) * 2019-01-18 2019-03-06 Univ Birmingham Drug delivery system
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran
US20200237626A1 (en) * 2019-01-28 2020-07-30 Jamrm, Llc Anti-Aging Corrective and Protective Formulation and Methods
KR102203356B1 (ko) * 2019-01-28 2021-01-18 (주)더마펌 피부 노화방지 및 주름개선용 펩타이드 및 이를 포함하는 조성물
CA3131382A1 (en) * 2019-02-25 2020-09-03 Topix Pharmaceuticals, Inc. Methods, compositions, sheets for therapeutic skin treatments
CN110257140B (zh) * 2019-06-17 2022-02-15 厦门路辉科技有限公司 一种光学高效芯取磨边液
WO2021021588A1 (en) * 2019-07-26 2021-02-04 Photokinetix Holdings Inc. Intravaginal devices, compositions and methods to treat atrophic vaginitis
CN110652484A (zh) * 2019-11-04 2020-01-07 武汉赛锐希斯科技有限公司 一种针对银屑病肤质日常维护的洗发水配方
CN110833514B (zh) * 2019-12-10 2023-05-09 广州赛莱拉干细胞科技股份有限公司 多肽冻干粉及其在制备抗衰老的化妆品中的应用
FR3104977B1 (fr) * 2019-12-20 2023-05-05 Oreal Sérum à base de rétinol
JP2023510381A (ja) * 2020-01-21 2023-03-13 エーエスシー・リジェニティー・リミテッド 皮膚の外観および再生を改善する新規なペプチドを含む局所投与用の化粧品製剤
US12077780B2 (en) * 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
WO2021173160A1 (en) * 2020-02-28 2021-09-02 Chanda Zaveri Hair growth and scalp preparations
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
CN111939458A (zh) * 2020-08-25 2020-11-17 四川大学 一种具有超薄柔性背衬层的微针贴片及其制备方法
FR3117014B1 (fr) * 2020-12-07 2024-01-12 Oreal Compositions de soin de la peau incluant l’acide azélaïque et procédés de fabrication d’une composition de soin de la peau
US11464727B2 (en) * 2020-09-29 2022-10-11 Serendipity Technologies Llc Reduced-cost cosmetic formulations that reduce visible signs of ageing
US20240082198A1 (en) * 2020-10-01 2024-03-14 Emergent Product Development Gaithersburg Inc. Stabilized alkyl nitrite compositions
WO2022140467A1 (en) * 2020-12-21 2022-06-30 Samson Pharma, Llc Topical compositions and methods of treating skin diseases and conditions with such compositions
US20220218584A1 (en) * 2021-01-13 2022-07-14 Allergan Sales, Llc Topical composition and method of use
WO2022157587A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A composition comprising lidocaine, l-carnosine and dexpanthenol
CN114469766A (zh) * 2021-02-02 2022-05-13 江苏巴帝恩生物科技有限公司 一种含葡萄糖电解质的保湿及改善肌肤屏障的化妆品组成物
KR102259668B1 (ko) * 2021-03-31 2021-06-01 신승연 프로테오글리칸-함유 크림 화장료 조성물 및 그의 제조방법
CN113376269A (zh) * 2021-05-14 2021-09-10 广东药科大学 一种十一烯酰基苯丙氨酸的含量测定方法
US12208150B2 (en) 2021-05-20 2025-01-28 Shielded, Beauty, LLC Antimicrobial skincare composition
US12171859B2 (en) * 2021-05-25 2024-12-24 Allergan Sales, Llc Topical composition and method of use
CN113368004B (zh) * 2021-06-15 2022-07-29 郑州三铠化妆品有限公司 一种具有抗衰修复功效的多肽组合物及其制备方法与应用
CN113440435B (zh) * 2021-07-07 2022-08-09 珀莱雅化妆品股份有限公司 一种皮肤抗衰老组合物的制备方法
TWI818301B (zh) * 2021-08-20 2023-10-11 富比積生物科技股份有限公司 寡肽於治療牙齦發炎和牙齦萎縮及修復口腔黏膜之用途
KR20240074854A (ko) * 2021-10-07 2024-05-28 3헬릭스, 인코포레이티드 생물학적 활성 콜라겐 하이브리드화 펩티드
US20230129072A1 (en) * 2021-10-22 2023-04-27 Vaginal Biome Science, Inc. System, product and method for maintaining the vaginal microbiome
US20230130124A1 (en) * 2021-10-25 2023-04-27 Cosmed Pharmaceutical Co., Ltd. Cosmetic microneedle
CN114392393A (zh) * 2021-12-17 2022-04-26 重庆米茜尔医疗美容门诊部有限公司 一种用于皮肤自我修复的皮下注射组合物及其使用方法
CN113956244B (zh) * 2021-12-21 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种用于皮肤复新的肌肽衍生物及其用途
US20230201105A1 (en) * 2021-12-23 2023-06-29 Guangen Xiang Lip Gloss Formulation
CN114369904A (zh) * 2021-12-24 2022-04-19 浙江鹿达科技有限公司 一种抗菌无纺布卫生材料及其制备工艺
KR102792529B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102792531B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102788413B1 (ko) * 2021-12-27 2025-03-31 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102792530B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
CN114452270B (zh) * 2022-01-19 2022-09-27 广东省第二中医院（广东省中医药工程技术研究院） 一种用于治疗骨关节炎的微针贴及其制备方法
CN114344217B (zh) * 2022-01-24 2024-07-09 深圳市琉璃光生物科技有限公司 一种膏状抗氧化护肤品及其生产工艺
CN115024997B (zh) * 2022-05-24 2023-11-17 彭氏(惠州)实业发展有限公司 具有抗皮肤衰老功效的化妆品组合物
CN115161274A (zh) * 2022-06-08 2022-10-11 菲尔生物工程技术有限公司 一种脂肪干细胞提取物的抗皱精华液及其制备方法
CN115261419B (zh) * 2022-07-23 2023-07-21 广州市博之越精细化工有限公司 一种γ-聚谷氨酸钠溶液的制备方法
CN115607467B (zh) * 2022-09-27 2023-05-30 谢志辉生物医药研究院(广州)有限公司 一种含有壬二酸的低刺激性与美白、控油组合物
US20250339361A1 (en) 2022-11-02 2025-11-06 Nutrition & Biosciences USA 4, Inc. Compositions comprising xanthan gum and crystalline alpha-1,3-glucan
KR102796308B1 (ko) * 2022-11-15 2025-04-17 웰펩 주식회사 가려움 유발 사이토카인 제어 효과가 우수한 펩티도미메틱 및 이를 포함하는 화장료 조성물
KR20240086708A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR20240086709A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
US12134792B1 (en) 2023-05-03 2024-11-05 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
US12351620B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
US12351621B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Composite collagen product and method of making thereof
CN116850081A (zh) * 2023-07-27 2023-10-10 上海君裕生物科技集团有限公司 一种用于敏感肌的修护组合物，冻干面膜及其制备方法
US20250066991A1 (en) * 2023-08-21 2025-02-27 Spora Cayman Holdings Limited Nanoemulsions for internal humectation of mycelium-based textiles
KR102620622B1 (ko) * 2023-09-08 2024-01-04 주식회사 제이포셀 보관 안정성이 향상된 egf를 함유하는 화장료 조성물
WO2025072416A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
WO2025072417A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
WO2025072419A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences Usa 1, Llc Crosslinked alpha-glucan derivatives
US12467171B2 (en) 2023-10-13 2025-11-11 Spora Cayman Holdings Limited Large-scale production of mycelium-based textiles at mushroom farm facilities
US12377156B2 (en) * 2023-10-24 2025-08-05 Neuvian Ip Holdings, Llc Compositions and methods for treatment of wounds and inflammatory skin conditions
CN117731544B (zh) * 2023-12-19 2024-11-15 广州集妍化妆品科技有限公司 一种含杏仁酸的具有靶向透皮递送功能的淡斑淡印美白增效组合物、其制备方法及其应用
CN117838563A (zh) * 2024-01-09 2024-04-09 杭州悦萱堂化妆品有限公司 一种抗糖复合物及抗糖化妆剂组合物及制备方法
CN117982629B (zh) * 2024-02-19 2024-07-19 北京盛美诺生物技术有限公司 一种iii型小分子胶原蛋白肽在改善面部肤质中的应用
US12409204B1 (en) * 2024-03-08 2025-09-09 Neuvian Ip Holdings, Llc Compositions and methods for hair treatment
WO2025199079A1 (en) 2024-03-20 2025-09-25 Nutrition & Biosciences USA 4, Inc. Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages
CN118178262A (zh) * 2024-03-30 2024-06-14 上海尊雅实业有限公司 一种美白抗衰组合物及其制备方法、应用
WO2025259983A1 (en) * 2024-06-13 2025-12-18 Colgate-Palmolive Company Skin care compositions
CN118557794B (zh) * 2024-07-31 2025-01-07 杭州科腾生物制品有限公司 一种注射用多肽透明质酸钠复合溶液及其制备方法
CN119868193B (zh) * 2025-03-28 2025-07-25 杭州湃肽生化科技有限公司 一种可用于医美术后的抗炎抗衰化妆品

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810828A (zh) * 2006-03-03 2006-08-02 华东师范大学 一种脂肪酸－肌肽复合物及其制备方法
CN1893911A (zh) * 2003-11-17 2007-01-10 赛德玛公司 含有四肽和三肽混合物的配方
CN101297027A (zh) * 2005-10-24 2008-10-29 惠氏公司 使用抗衰老化合物生产蛋白质的方法
CN101472944A (zh) * 2006-06-13 2009-07-01 赫里克斯生物医疗公司 用于诱导细胞外基质蛋白合成的肽片段
CN101878019A (zh) * 2007-11-30 2010-11-03 赢创高施米特有限公司 含有具有基序gx1x2g、px1x2p或者px1x2k的四肽的个人护理和化妆品组合物
FR2946251A1 (fr) * 2009-06-08 2010-12-10 Oreal Composition cosmetique comprenant un derive d'acide salicylique et de la carnosine.
WO2012164488A2 (en) * 2011-06-01 2012-12-06 Sederma New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
FR2701948B1 (fr) 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
FR2711990B1 (fr) 1993-11-05 1995-12-08 Exsymol Sa Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
AU6990796A (en) 1996-08-23 1998-03-06 Sederma Sa Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
FR2756565B1 (fr) 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2783169B1 (fr) 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
FR2791684B1 (fr) 1999-03-30 2001-05-11 Sederma Sa Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse
FR2802413B1 (fr) 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
AUPQ515000A0 (en) 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
FR2805744B1 (fr) 2000-03-03 2006-08-25 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le dipeptide val-trp pour faciliter le drainage lymphatique et diminuer la masse adipeuse
FR2810323B1 (fr) 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
EP1455744A2 (de) * 2001-10-13 2004-09-15 Beiersdorf AG Kosmetische und/oder dermatologische wirkstoffkombination
US7795203B2 (en) 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
WO2004064866A1 (ja) 2003-01-20 2004-08-05 Innovative Vision Products, Inc. カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
BRPI0410074B1 (pt) 2003-05-08 2020-03-10 Dsm Ip Assets B.V. Compostos, processo para a preparação e uso dos mesmos, composição, e, processo para o incremento da produção de colágeno e/ou elastina na pele humana e/ou para o retardamento ou o tratamento do envelhecimento da pele
FR2854897B1 (fr) 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
ES2261036B1 (es) * 2004-10-05 2007-12-16 Lipotec, S.A. Peptidos sinteticos que disminuyen o eliminan las bolsas formadas bajo el contorno inferior de los ojos y su uso en composiciones cosmeticas o dermofarmaceuticas.
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
JP5697869B2 (ja) 2006-06-01 2015-04-08 セラピューティック ペプタイズ，インコーポレーテッド 高分子バイオサーファクタント
ES2342754B1 (es) * 2008-10-03 2011-05-11 Lipotec, S.A. Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
TWI442940B (zh) 2009-01-16 2014-07-01 Neocutis Sa 鈣螯合組成物及治療皮膚色素沈著病症和病況的方法
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
JP2012528888A (ja) 2009-06-05 2012-11-15 アーシエックス セラピューティックス， インコーポレイテッド 眼科用配合剤、その製造方法およびその使用方法
JP2013521300A (ja) 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
CA2902938C (en) 2013-03-13 2021-06-01 Neocutis Sa Peptides for skin rejuvenation and methods of using the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1893911A (zh) * 2003-11-17 2007-01-10 赛德玛公司 含有四肽和三肽混合物的配方
CN101297027A (zh) * 2005-10-24 2008-10-29 惠氏公司 使用抗衰老化合物生产蛋白质的方法
CN1810828A (zh) * 2006-03-03 2006-08-02 华东师范大学 一种脂肪酸－肌肽复合物及其制备方法
CN101472944A (zh) * 2006-06-13 2009-07-01 赫里克斯生物医疗公司 用于诱导细胞外基质蛋白合成的肽片段
CN101878019A (zh) * 2007-11-30 2010-11-03 赢创高施米特有限公司 含有具有基序gx1x2g、px1x2p或者px1x2k的四肽的个人护理和化妆品组合物
FR2946251A1 (fr) * 2009-06-08 2010-12-10 Oreal Composition cosmetique comprenant un derive d'acide salicylique et de la carnosine.
WO2012164488A2 (en) * 2011-06-01 2012-12-06 Sederma New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
action of carnosine and beta-alanine on wound healing;Nagai K等;《Surgery》;19861231;第5卷(第100期);第815-821页 *
Bioactive tetrapeptide GEKG boosts extracellular matrix formation:in vitro and in vivo molecular and clinical proof;Mike Farwick等;《Experimental Dermatology》;20110622;第7卷(第20期);第600-613页 *

Also Published As

Publication number Publication date
MX360649B (es) 2018-11-12
AR095276A1 (es) 2015-09-30
JP2016516023A (ja) 2016-06-02
US9375398B2 (en) 2016-06-28
US20200093799A1 (en) 2020-03-26
WO2014140890A3 (en) 2015-04-09
AU2014229557B2 (en) 2017-12-07
CN105189531A (zh) 2015-12-23
US10543195B2 (en) 2020-01-28
JP6326601B2 (ja) 2018-05-23
MX2015011498A (es) 2016-05-31
US20160271109A1 (en) 2016-09-22
SG11201506069RA (en) 2015-09-29
TW201521758A (zh) 2015-06-16
US11331305B2 (en) 2022-05-17
RU2015131719A (ru) 2017-04-20
CA2902938A1 (en) 2014-09-18
KR102276326B1 (ko) 2021-07-13
US20140309173A1 (en) 2014-10-16
CA2902938C (en) 2021-06-01
WO2014140890A2 (en) 2014-09-18
RU2666533C2 (ru) 2018-09-11
HK1212363A1 (en) 2016-06-10
EP2970382B1 (en) 2019-09-25
AU2014229557A1 (en) 2015-10-22
EP2970382A2 (en) 2016-01-20
TWI652066B (zh) 2019-03-01
KR20150126621A (ko) 2015-11-12

Similar Documents

Publication Publication Date Title
US11331305B2 (en) Peptides for skin rejuvenation and methods of using the same
ES2381359T3 (es) Composiciones que contienen mezclas de tetrapéptidos y tripéptidos
CA2907495C (en) Antioxidant compositions and methods of using the same
EP1638991B1 (fr) Composition cosmetique ou dermopharmaceutique pour reduire les signes du vieillissement cutane
CN101790536A (zh) 新化合物、其在美容和药疗美容应用中的用途以及包含其的组合物
WO2006114657A1 (en) Lys-thr dipeptides and their use
KR20070043449A (ko) 나노에멀젼 피부노화방지 화장료 조성물
JP2010006844A (ja) インスリン様成長因子−１分泌促進剤
JP4950571B2 (ja) コラーゲン産生促進能を有する組成物
WO2016127902A1 (zh) 一种包含p-113肽的组合物在制备具有保湿功能的化妆品中的用途
JP5423002B2 (ja) 亜鉛を有効成分として含有するコラーゲン合成促進剤
JP2024543222A (ja) 脂肪分解ペプチド
JP6741014B2 (ja) 保湿剤及びこれを含む化粧料
JP2005336133A (ja) 皮膚外用剤
HK1212363B (zh) 用於皮肤复新的肽及其使用方法
WO2025096719A1 (en) Bioactive walnut peptides and compositions for topical treatment of skin
HK1146730A (en) Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
KR20060065814A (ko) 올리고뉴클레오타이드를 포함하는 피부 노화 방지제

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1212363

Country of ref document: HK

TA01 Transfer of patent application right

Effective date of registration: 20180115

Address after: geneva

Applicant after: Anteis S. A.

Address before: Swiss

Applicant before: Neocutis SA

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant